Advertisement
Screener

Clovis Oncology, Inc. Diluted Shares Outstanding (Weighted Average)

Clovis Oncology, Inc. Diluted Shares Outstanding (Weighted Average)

Clovis Oncology, Inc. reported Diluted Shares Outstanding (Weighted Average) of 144.63 million shares for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.

Discontinued › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2022-11-09

  • Clovis Oncology, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-09-30 was 144.63M shares, a 19.31% increase year-over-year.
  • Clovis Oncology, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-06-30 was 144.04M shares, a 32.78% increase year-over-year.
  • Clovis Oncology, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-03-31 was 138.21M shares, a 32.58% increase year-over-year.
  • Clovis Oncology, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-12-31 was 128.47M shares, a 32.88% increase year-over-year.
  • Clovis Oncology, Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 115.53M shares, a 37.03% increase from fiscal 2020.
  • Clovis Oncology, Inc. weighted average number of shares outstanding, diluted for fiscal 2020 was 84.31M shares, a 56.49% increase from fiscal 2019.
  • Clovis Oncology, Inc. weighted average number of shares outstanding, diluted for fiscal 2019 was 53.87M shares.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 9 monthWeighted Average Number of Shares Outstanding, Diluted 12 month
2022-09-30144.63M shares
10-Q · filed 2022-11-09
144.33M shares
derived: average of 2 quarters · filed 2022-11-09
142.31M shares
10-Q · filed 2022-11-09
138.83M shares
derived: average of 4 quarters · filed 2022-11-09
2022-06-30144.04M shares
10-Q · filed 2022-08-08
141.14M shares
10-Q · filed 2022-08-08
136.90M shares
derived: average of 3 quarters · filed 2022-08-08
132.98M shares
derived: average of 4 quarters · filed 2022-11-09
2022-03-31138.21M shares
10-Q · filed 2022-05-05
133.34M shares
derived: average of 2 quarters · filed 2022-05-05
129.30M shares
derived: average of 3 quarters · filed 2022-11-09
124.09M shares
derived: average of 4 quarters · filed 2022-11-09
2021-12-31128.47M shares
10-K · filed 2022-02-24
124.84M shares
derived: average of 2 quarters · filed 2022-11-09
119.39M shares
derived: average of 3 quarters · filed 2022-11-09
115.53M shares
10-K · filed 2022-02-24
2021-09-30121.22M shares
10-Q · filed 2022-11-09
114.85M shares
derived: average of 2 quarters · filed 2022-11-09
111.38M shares
10-Q · filed 2022-11-09
107.66M shares
derived: average of 4 quarters · filed 2022-11-09
2021-06-30108.48M shares
10-Q · filed 2022-08-08
106.38M shares
10-Q · filed 2022-08-08
103.14M shares
derived: average of 3 quarters · filed 2022-08-08
99.42M shares
derived: average of 4 quarters · filed 2022-08-08
2021-03-31104.25M shares
10-Q · filed 2022-05-05
102.25M shares
10-K · filed 2022-02-24
100.46M shares
derived: average of 2 quarters · filed 2022-05-05
96.39M shares
derived: average of 3 quarters · filed 2022-05-05
92.41M shares
derived: average of 4 quarters · filed 2022-05-05
2020-12-3196.68M shares
10-K · filed 2022-02-24
92.47M shares
derived: average of 2 quarters · filed 2022-02-24
88.46M shares
derived: average of 3 quarters · filed 2022-02-24
84.31M shares
10-K · filed 2022-02-24
2020-09-3088.25M shares
10-K · filed 2022-02-24
84.35M shares
derived: average of 2 quarters · filed 2022-02-24
80.15M shares
10-Q · filed 2021-11-03
2020-06-3080.45M shares
10-K · filed 2022-02-24
76.06M shares
10-Q · filed 2021-08-04
2020-03-3171.66M shares
10-K · filed 2022-02-24
2019-12-3153.87M shares
10-K · filed 2022-02-24